3 reasons to buy Ansell Limited

One analyst has a "buy" recommendation on Ansell. I outline 3 reasons why the stock has upside in the short-term.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Deutsche Bank has upgraded Ansell Limited (ASX: ANN) to a "buy" with a 12-month price target of $22 a share. Ansell shares are currently trading at $20. Analysts at Deutsche Bank stated that:

"Despite a frustratingly slow economic recovery and a weak first-half result, we believe Ansell is on track to deliver a FY14 result within its guidance range, thanks to materially weaker input costs and stable selling prices".

I agree with the above analyst recommendation. Ansell's share price should outperform as a result of the following:

1) Ansell has provided the market with guidance that it expects to deliver 15% second-half FY14 net profit growth which implies a forward price earnings ratio of 15 times. Therefore, at this price the stock looks cheap, especially when compared to other industrial companies on the ASX.

2) Ansell's margins will continue to improve as a result of record-low commodity prices. Ansell stated that latex prices fell by 16% in the second half of FY14 and average nitrile pricing was down by 14%. The continued weakness in commodity prices will result in significant cost savings for Ansell for FY14 and FY15.

3) Ansell will continue to benefit from improving economic conditions in the United States. The United States reported impressive employment data in April which is a catalyst for an improvement in industrial conditions. Ansell derives 45% of its industrial earnings from the United States.

Ansell currently appears cheap based on the company's guidance. Furthermore, it is highly likely that earnings will be higher than forecast as a result of a robust US economy and record low commodity prices.

Motley Fool contributor Bradley Murphy does not own shares in any company mentioned in this article.

More on ⏸️ Investing

A white and black robot in the form of a human being stands in front of a green graphic holding a laptop and discussing robotics and automation ASX shares
Technology Shares

Joining the revolution: How I'd invest in ASX AI shares right now

Advances in artificial intelligence (AI) could usher in a new industrial revolution. Here’s how you can invest in it.

Read more »

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »